Georgia McGaughey

About Georgia McGaughey

SCIENTIFIC LEADER LEVERAGING DATA AND ADVANCED ANALYTICS with impact from research to FDA approval for small molecules and genetic therapies. Georgia has over 30 years of corporate experience in drug discovery and digital transformation obtained by working at Pfizer, Merck and Vertex. As a global leader, she is known for managing research data science teams which drive value for the business by discovering small molecules and cell and genetic therapies for unmet medical needs using transformative and innovative computational sciences approaches. She has led teams from basic research to FDA approval and has specialized experience in bringing medicines to market in rare diseases and leverages Artificial Intelligence (AI) to accelerate the drug discovery process where appropriate. She is known as a skilled mentor, global leader, and an exceptionally collaborative member of drug discovery programs.

Experience

1. Board Member

   Little Sparrows Technologies

   Jun 2024 — Present · Woburn, MA, US

   Little Sparrows Technologies develops and manufactures medtech products. As an example, the bili-hut, is a high-intensity phototherapy device for treating jaundiced babies. As a Board member I provide strategic direction for the company at a global level for device(s) distribution. Topics include both capital and operational expenditures and clinical trials.

Education

• Harvard Business School

  Advanced Management Program (AMP199)

  2020 — 2021

• Harvard Business School

  Women on Boards

  2023

• The University of Georgia

  PhD, Physical Chemistry

  1991 — 1995

Skills

• Medicinal Chemistry
• Biochemistry
• Docking
• Lifesciences
• Life Sciences
• Cheminformatics
• Computational Chemistry
• Bioinformatics
• Biotechnology
• Molecular Modeling
• Informatics
• Pharmaceutical Industry
• Drug Development
• Lead Change
• Organic Chemistry
• Protein Chemistry
• Drug Design
• Molecular Biology
• Chemistry
• Drug Discovery
• Organic Synthesis